Recent Quotes (30 days)

You have no recent quotes
chg | %

GlaxoSmithKline plc news

   Watch this stock
Showing stories 11 - 20 of about 174   

Articles published

GSK 1,412.00 +35.00 (2.54%)
price chart
Beat The FTSE 100 With SABMiller plc, GlaxoSmithKline plc And British ...
With the FTSE 100 having fallen by over 8% during the last month, beating the returns on the index has become a priority for a number of UK investors.
Related articles »  
GlaxoSmithKline plc Upgraded at Barclays (GSK)
Barclays upgraded shares of GlaxoSmithKline plc (NYSE:GSK) from an equal weight rating to an overweight rating in a report released on Thursday.
Related articles »  
GlaxoSmithKline plc Short Interest Down 42.0% in September (GSK)
GlaxoSmithKline plc logo Shares of GlaxoSmithKline plc (NYSE:GSK) were the target of a significant decrease in short interest in the month of September.
GlaxoSmithKline plc Upgraded to "Overweight" at Barclays (GSK)
GlaxoSmithKline plc logo GlaxoSmithKline plc (LON:GSK) was upgraded by equities researchers at Barclays to an ´┐Żoverweight´┐Ż rating in a research report issued on Thursday.
Related articles »  
GlaxoSmithKline Plc. share price up, announces better-than-expected third ...
GlaxoSmithKline Plc reported third-quarter profit that surpassed analysts' projections and unveiled a new cost-saving program and management structure, as sales in the U.S.
Panmure Gordon Lowers GlaxoSmithKline plc Price Target to GBX 1425 (GSK)
GlaxoSmithKline plc logo GlaxoSmithKline plc (LON:GSK) had its price target reduced by Panmure Gordon from GBX 1,600 ($25.75) to GBX 1,425 ($22.93) in a research report sent to investors on Wednesday morning.
Why Have GlaxoSmithKline plc And AstraZeneca plc Followed The FTSE 100 ...
Investors tend to turn to big blue-chip dividend payers at times of market volatility, and in times past the steady earnings of pharma giants GlaxoSmithKline (LSE: GSK) and AstraZeneca (LSE: AZN) have been a particular source of comfort when the market ...
Related articles »  
Analyst Update: Alcatel Lucent SA (ADR), AT&T Inc., and GlaxoSmithKline plc ...
Analysts are weighing in today on networking firm Alcatel Lucent SA (ADR) (NYSE:ALU), telecom issue AT&T Inc. (NYSE:T), and pharmaceutical power GlaxoSmithKline plc (ADR) (NYSE:GSK). Here's a quick look at today's brokerage notes on ALU, T, and ...
Related articles »  
GlaxoSmithKline plc (GSK) Posts Quarterly Earnings Results, Beats Estimates ...
GlaxoSmithKline plc logo GlaxoSmithKline plc (NYSE:GSK) posted its quarterly earnings results on Wednesday. The company reported $0.90 EPS for the quarter, beating the Thomson Reuters consensus estimate of $0.79 by $0.11, AnalystRatings.
A Blue-Chip Starter Portfolio: GlaxoSmithKline plc, BHP Billiton plc And Rolls ...
Every quarter I take a look at the largest FTSE 100 companies in each of the index's 10 industries to see how they shape up as a potential 'starter' portfolio.
Traders Recap -GlaxoSmithKline plc (ADR)(NYSE:GSK), Dollar Tree, Inc ...  Techsonian (press release)
Related articles »